Detalhe da pesquisa
1.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
PLoS Med
; 21(2): e1004356, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377166
2.
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Clin Infect Dis
; 76(12): 2090-2097, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815322
3.
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis.
Clin Infect Dis
; 73(9): e3459-e3467, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915203
4.
Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 73(7): e2278-e2284, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761083
5.
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
PLoS Med
; 18(12): e1003875, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914696
6.
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.
Antimicrob Agents Chemother
; 65(12): e0170521, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606336
7.
Impact of T-Cell Xtend on T-SPOT.TB Assay in High-Risk Individuals after Delayed Blood Sample Processing.
J Clin Microbiol
; 59(5)2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658266
8.
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
MMWR Recomm Rep
; 69(1): 1-11, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053584
9.
Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
Am J Respir Crit Care Med
; 201(5): 598-605, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711306
10.
Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis Infection.
Clin Infect Dis
; 71(5): 1320-1323, 2020 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773132
11.
Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
J Clin Microbiol
; 57(11)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462550
12.
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.
MMWR Morb Mortal Wkly Rep
; 68(19): 439-443, 2019 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099768
13.
Interferon-Gamma Release Assay-Based Screening for Pediatric Latent Tuberculosis Infection in an Urban Primary Care Network.
J Pediatr
; 200: 202-209, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866596
14.
Updates in the Treatment of Active and Latent Tuberculosis.
Semin Respir Crit Care Med
; 39(3): 297-309, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071545
15.
Latent tuberculosis infection: Opportunities and challenges.
Respirology
; 23(10): 893-900, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29901251
16.
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Ann Intern Med
; 167(10): 689-697, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114781
17.
Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.
J Clin Microbiol
; 55(2): 391-402, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27852671
18.
Reply to Swindells et al.: Trials of Tuberculosis-Preventive Therapy in People with HIV Infection.
Am J Respir Crit Care Med
; 202(2): 305-306, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282235
19.
Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
Am J Respir Crit Care Med
; 189(1): 77-87, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24299555
20.
Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease.
JAMA Netw Open
; 7(4): e244769, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38568690